NCT05691504 2026-03-19Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial CancersNational Cancer Institute (NCI)Phase 1 Recruiting42 enrolled
NCT03600701 2025-10-07Atezolizumab and Cobimetinib in Treating Patients With Metastatic, Recurrent, or Refractory Non-small Cell Lung CancerNational Cancer Institute (NCI)Phase 2 Active not recruiting51 enrolled